Clinical trials
Suspended Triple Negative Breast Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Laura Kennedy | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Cancer Institute (NCI) | 1 |
| NextPoint Therapeutics, Inc. | 1 |
| PACT Pharma, Inc. | 1 |
| Persephone Biosciences | 1 |
| Texas Tech University Health Sciences Center, El Paso | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colorectal Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Transitional Cell | 2 |
| Pancreatic Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Carcinoma, Renal Cell | 1 |
| Cholangiocarcinoma | 1 |
| Endometrial Neoplasms | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.